FCER2 and breast cancer: In our case, although we considered the possibility of metastatic BC when analyzing the mesenteric biopsy, the immunohistochemical profile clearly revealed a nodular, low-grade (grade I) follicular lymphoma (CD20+, CD10+, BCL2+, CD23+, CD3−, CD5− and cyclin D1−).